These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 35040414)

  • 21. Association of diabetes and hypertension with disease severity in covid-19 patients: A systematic literature review and exploratory meta-analysis.
    Parveen R; Sehar N; Bajpai R; Agarwal NB
    Diabetes Res Clin Pract; 2020 Aug; 166():108295. PubMed ID: 32623032
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diabetes, obesity, hypertension and risk of severe COVID-19: a protocol for systematic review and meta-analysis.
    Li C; Islam N; Gutierrez JP; Lacey B; Moolenaar RL; Richter P
    BMJ Open; 2021 Nov; 11(11):e051711. PubMed ID: 34836901
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tocilizumab in SARS-CoV-2 Patients with the Syndrome of Cytokine Storm: A Narrative Review.
    Kulanthaivel S; Kaliberdenko VB; Balasundaram K; Shterenshis MV; Scarpellini E; Abenavoli L
    Rev Recent Clin Trials; 2021; 16(2):138-145. PubMed ID: 32940187
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circulating Levels of Interleukin-6 and Interleukin-10, But Not Tumor Necrosis Factor-Alpha, as Potential Biomarkers of Severity and Mortality for COVID-19: Systematic Review with Meta-analysis.
    Udomsinprasert W; Jittikoon J; Sangroongruangsri S; Chaikledkaew U
    J Clin Immunol; 2021 Jan; 41(1):11-22. PubMed ID: 33128665
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence and predictors of death and severe disease in patients hospitalized due to COVID-19: A comprehensive systematic review and meta-analysis of 77 studies and 38,000 patients.
    Dorjee K; Kim H; Bonomo E; Dolma R
    PLoS One; 2020; 15(12):e0243191. PubMed ID: 33284825
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diabetes Mellitus during the Pandemic Covid-19: Prevalence, Pathophysiology, Mechanism, and Management: An updated overview.
    Rais N; Ahmad R; Ved A; Parveen K; Ishrat T; Prakash O; Shadab M; Bari DG; Siddiqui NA
    Curr Diabetes Rev; 2022; 18(3):e120721194712. PubMed ID: 34931983
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Obesity in COVID-19 era, implications for mechanisms, comorbidities, and prognosis: a review and meta-analysis.
    Aghili SMM; Ebrahimpur M; Arjmand B; Shadman Z; Pejman Sani M; Qorbani M; Larijani B; Payab M
    Int J Obes (Lond); 2021 May; 45(5):998-1016. PubMed ID: 33637951
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A consideration of publication-derived immune-related associations in Coronavirus and related lung damaging diseases.
    Geifman N; Whetton AD
    J Transl Med; 2020 Aug; 18(1):297. PubMed ID: 32746922
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diabetes as one of the long-term COVID-19 complications: from the potential reason of more diabetic patients' susceptibility to COVID-19 to the possible caution of future global diabetes tsunami.
    Sharbatdar Y; Mousavian R; Noorbakhsh Varnosfaderani SM; Aziziyan F; Liaghat M; Baziyar P; Yousefi Rad A; Tavakol C; Moeini AM; Nabi-Afjadi M; Zalpoor H; Kazemi-Lomedasht F
    Inflammopharmacology; 2023 Jun; 31(3):1029-1052. PubMed ID: 37079169
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Global prevalence and effect of comorbidities and smoking status on severity and mortality of COVID-19 in association with age and gender: a systematic review, meta-analysis and meta-regression.
    Chenchula S; Vidyasagar K; Pathan S; Sharma S; Chavan MR; Bhagavathula AS; Padmavathi R; Manjula M; Chhabra M; Gupta R; Amerneni KC; Ghanta MK; Mudda S
    Sci Rep; 2023 Apr; 13(1):6415. PubMed ID: 37076543
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical characteristics, laboratory outcome characteristics, comorbidities, and complications of related COVID-19 deceased: a systematic review and meta-analysis.
    Qiu P; Zhou Y; Wang F; Wang H; Zhang M; Pan X; Zhao Q; Liu J
    Aging Clin Exp Res; 2020 Sep; 32(9):1869-1878. PubMed ID: 32734576
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Association between Presence of Comorbidities and COVID-19 Severity: A Systematic Review and Meta-Analysis.
    Honardoost M; Janani L; Aghili R; Emami Z; Khamseh ME
    Cerebrovasc Dis; 2021; 50(2):132-140. PubMed ID: 33530081
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diabetic Patients with COVID-19 Complications: Insights into Prevalence, Prognosis, Combination Medications, and Underlying Mechanisms.
    Wal P; Dwivedi J; Wal A; Kushwaha S
    Curr Diabetes Rev; 2023; 19(7):e250822208008. PubMed ID: 36028964
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Efficacy and Potential Mechanisms of Metformin in the Treatment of COVID-19 in the Diabetics: A Systematic Review.
    Zangiabadian M; Nejadghaderi SA; Zahmatkesh MM; Hajikhani B; Mirsaeidi M; Nasiri MJ
    Front Endocrinol (Lausanne); 2021; 12():645194. PubMed ID: 33815295
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epigenetic modifications associated with genes implicated in cytokine storm: The potential biotherapeutic effects of vitamins and minerals in COVID-19.
    Muhammad A; Forcados GE; Sani H; Ndidi US; Adamu A; Katsayal BS; Sadiq IZ; Abubakar YS; Sulaiman I; Abubakar IB; Yusuf AP; Malami I; Ibrahim S; Abubakar MB
    J Food Biochem; 2022 May; 46(5):e14079. PubMed ID: 35060145
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The roles of critical pro-inflammatory cytokines in the drive of cytokine storm during SARS-CoV-2 infection.
    Qudus MS; Tian M; Sirajuddin S; Liu S; Afaq U; Wali M; Liu J; Pan P; Luo Z; Zhang Q; Yang G; Wan P; Li Y; Wu J
    J Med Virol; 2023 Apr; 95(4):e28751. PubMed ID: 37185833
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An Assessment on Impact of COVID-19 Infection in a Gender Specific Manner.
    Agrawal H; Das N; Nathani S; Saha S; Saini S; Kakar SS; Roy P
    Stem Cell Rev Rep; 2021 Feb; 17(1):94-112. PubMed ID: 33029768
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical outcomes in COVID-19 patients treated with tocilizumab: An individual patient data systematic review.
    Antwi-Amoabeng D; Kanji Z; Ford B; Beutler BD; Riddle MS; Siddiqui F
    J Med Virol; 2020 Nov; 92(11):2516-2522. PubMed ID: 32436994
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epidemiology, risk factors and prognosis of cardiovascular disease in the Coronavirus Disease 2019 (COVID-19) pandemic era: a systematic review.
    Pepera G; Tribali MS; Batalik L; Petrov I; Papathanasiou J
    Rev Cardiovasc Med; 2022 Jan; 23(1):28. PubMed ID: 35092220
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Deciphering the COVID-19 cytokine storm: Systematic review and meta-analysis.
    Mulchandani R; Lyngdoh T; Kakkar AK
    Eur J Clin Invest; 2021 Jan; 51(1):e13429. PubMed ID: 33058143
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.